WEHI-345 analog structure
|
Common Name | WEHI-345 analog | ||
---|---|---|---|---|
CAS Number | 1354825-62-9 | Molecular Weight | 415.491 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 688.0±55.0 °C at 760 mmHg | |
Molecular Formula | C23H25N7O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 369.9±31.5 °C |
Use of WEHI-345 analogWEHI-345 (analog) is a Src inhibitor, extracted from patent WO/2012003544A1, compound example 71.Target:SrcWEHI-345 (analog) is a protein kinase inhibitor. A family of proto-oncogenic TPKs referred to herein as SFKs (Src family kinases) have provided researchers with a better understanding of the mechanism of cancer as a disease state where normally healthy cellular signalling is disrupted. |
Name | WEHI-345 analog |
---|---|
Synonym | More Synonyms |
Description | WEHI-345 (analog) is a Src inhibitor, extracted from patent WO/2012003544A1, compound example 71.Target:SrcWEHI-345 (analog) is a protein kinase inhibitor. A family of proto-oncogenic TPKs referred to herein as SFKs (Src family kinases) have provided researchers with a better understanding of the mechanism of cancer as a disease state where normally healthy cellular signalling is disrupted. |
---|---|
Related Catalog | |
References |
[1]. Jonathan Bayldon Baell, et al. Protein kinase inhibitors and methods of treatment. WO2012003544A1. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 688.0±55.0 °C at 760 mmHg |
Molecular Formula | C23H25N7O |
Molecular Weight | 415.491 |
Flash Point | 369.9±31.5 °C |
Exact Mass | 415.212067 |
LogP | 2.76 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.678 |
Storage condition | 2-8℃ |
N-{2-[4-Amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl}-3-methyl-2-pyridinecarboxamide |
2-Pyridinecarboxamide, N-[2-[4-amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methyl- |